AI
Wednesday, September 15, 2021 10:33:08 AM
VeryJerry
6m
$HGEN
interesting update to the enrollment number for NIH trial - total trial now up to 550, 60% enrolled to date. And for the first time we see that NIH is targeting specifically 400 in the <150 CRP which is likely the number needed to power the recently updated primary endpoint. It’s possible the trial could conclude early if the trial increases its enrollment in this subgroup at a higher rate than the rest of the population.
6m
$HGEN
interesting update to the enrollment number for NIH trial - total trial now up to 550, 60% enrolled to date. And for the first time we see that NIH is targeting specifically 400 in the <150 CRP which is likely the number needed to power the recently updated primary endpoint. It’s possible the trial could conclude early if the trial increases its enrollment in this subgroup at a higher rate than the rest of the population.
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
